The Body PRO

Top 25 Most-Viewed Articles on The Body PRO

	The Once and Future King: What Will Replace Atripla Atop the First-Line HIV Treatment Realm?
	The End of HIV Drug Development as We Know It?
	HIV JournalView: Top 10 HIV Clinical Developments of 2009
	The First Man to Be Cured of HIV: An Update on the Fascinating Story
	HIV Vaccine Trial Lessons: What Researchers Learned From the STEP Study's Failure and the RV144 ("Thai") Study's Success
	Rapid HIV Antibody Testing May Have Limitations in a Population With High Incidence of HIV
	Pozitively Healthy: A Gay Man's Guide to Sex and Health in Canada
	Upgrading Circumcision Tools to Prevent HIV
	Why There's Such an HIV/AIDS Disparity Among U.S. Blacks and Hispanics -- and What to Do About It
	CROI 2010 Wrap-Up: The Evolution of Antiretroviral Therapy
	The New Quad on the Block: Gilead's Four-Drug, Fixed-Dose Combination With a Novel Booster Sails Through Phase 2 Trials
	HIV Does Not Worsen H1N1-Related Complications (and Vice Versa), Study Finds
	HCV Survival in Syringes Affected by Syringe Type, Time and Temperature
	CROI 2010 Wrap-Up: The HIV Drug Development Pipeline
	Smoking Cessation Reduces CVD Risk in HIV
	Hepatitis C Transmission Among HIV-Infected Men Who Have Sex With Men Is Occurring Primarily in Men Older Than 35
	Shorter Duration of TB-Prevention Therapy Including Ethambutol May Be Effective, Study Suggests
	HIV/AIDS Research Should Focus More Heavily on Ending the Pandemic, NIAID Director Says
	ACTG 5202 Substudy Finds Little Lipoatrophy but Signs of Bone Loss Across the Board; Devil Is in the Details
	HIV Frontlines: HIV/AIDS and Homophobia in Jamaica
	Fighting HIV in Communities of Color
	Future of AIDS Gels May Lie in Drugs, Experts Say
	Why Vicriviroc Failed in Its Phase 3 Trials -- and What It May Mean for Future Studies in HIV Treatment-Experienced People
	Can a Trofile Assay Be Used to Predict HIV Disease Progression?
	Whatever Happened to H1N1 (Swine Flu) and HIV? New Answers at CROI 2010

This article was provided by The Body PRO.

The Once and Future King: What Will Replace Atripla Atop the First-Line HIV Treatment Realm?

The End of HIV Drug Development as We Know It?

HIV JournalView: Top 10 HIV Clinical Developments of 2009

The First Man to Be Cured of HIV: An Update on the Fascinating Story

HIV Vaccine Trial Lessons: What Researchers Learned From the STEP Study's Failure and the RV144 ("Thai") Study's Success

More >>

The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.